Cargando…
An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research
Survival analysis is a set of methods for statistical inference concerning the time until the occurrence of an event. One of the main objectives of survival analysis is to evaluate the effects of different covariates on event time. Although the proportional hazards model is widely used in survival a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332026/ https://www.ncbi.nlm.nih.gov/pubmed/35893205 http://dx.doi.org/10.3390/healthcare10081383 |
_version_ | 1784758547868811264 |
---|---|
author | Aida, Haro Hayashi, Kenichi Takeuchi, Ayano Sugiyama, Daisuke Okamura, Tomonori |
author_facet | Aida, Haro Hayashi, Kenichi Takeuchi, Ayano Sugiyama, Daisuke Okamura, Tomonori |
author_sort | Aida, Haro |
collection | PubMed |
description | Survival analysis is a set of methods for statistical inference concerning the time until the occurrence of an event. One of the main objectives of survival analysis is to evaluate the effects of different covariates on event time. Although the proportional hazards model is widely used in survival analysis, it assumes that the ratio of the hazard functions is constant over time. This assumption is likely to be violated in practice, leading to erroneous inferences and inappropriate conclusions. The accelerated failure time model is an alternative to the proportional hazards model that does not require such a strong assumption. Moreover, it is sometimes plausible to consider the existence of cured patients or long-term survivors. The survival regression models in such contexts are referred to as cure models. In this study, we consider the accelerated failure time cure model with frailty for uncured patients. Frailty is a latent random variable representing patients’ characteristics that cannot be described by observed covariates. This enables us to flexibly account for individual heterogeneities. Our proposed model assumes a shifted gamma distribution for frailty to represent uncured patients’ heterogeneities. We construct an estimation algorithm for the proposed model, and evaluate its performance via numerical simulations. Furthermore, as an application of the proposed model, we use a real dataset, Specific Health Checkups, concerning the onset of hypertension. Results from a model comparison suggest that the proposed model is superior to existing alternatives. |
format | Online Article Text |
id | pubmed-9332026 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93320262022-07-29 An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research Aida, Haro Hayashi, Kenichi Takeuchi, Ayano Sugiyama, Daisuke Okamura, Tomonori Healthcare (Basel) Article Survival analysis is a set of methods for statistical inference concerning the time until the occurrence of an event. One of the main objectives of survival analysis is to evaluate the effects of different covariates on event time. Although the proportional hazards model is widely used in survival analysis, it assumes that the ratio of the hazard functions is constant over time. This assumption is likely to be violated in practice, leading to erroneous inferences and inappropriate conclusions. The accelerated failure time model is an alternative to the proportional hazards model that does not require such a strong assumption. Moreover, it is sometimes plausible to consider the existence of cured patients or long-term survivors. The survival regression models in such contexts are referred to as cure models. In this study, we consider the accelerated failure time cure model with frailty for uncured patients. Frailty is a latent random variable representing patients’ characteristics that cannot be described by observed covariates. This enables us to flexibly account for individual heterogeneities. Our proposed model assumes a shifted gamma distribution for frailty to represent uncured patients’ heterogeneities. We construct an estimation algorithm for the proposed model, and evaluate its performance via numerical simulations. Furthermore, as an application of the proposed model, we use a real dataset, Specific Health Checkups, concerning the onset of hypertension. Results from a model comparison suggest that the proposed model is superior to existing alternatives. MDPI 2022-07-25 /pmc/articles/PMC9332026/ /pubmed/35893205 http://dx.doi.org/10.3390/healthcare10081383 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Aida, Haro Hayashi, Kenichi Takeuchi, Ayano Sugiyama, Daisuke Okamura, Tomonori An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research |
title | An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research |
title_full | An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research |
title_fullStr | An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research |
title_full_unstemmed | An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research |
title_short | An Accelerated Failure Time Cure Model with Shifted Gamma Frailty and Its Application to Epidemiological Research |
title_sort | accelerated failure time cure model with shifted gamma frailty and its application to epidemiological research |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332026/ https://www.ncbi.nlm.nih.gov/pubmed/35893205 http://dx.doi.org/10.3390/healthcare10081383 |
work_keys_str_mv | AT aidaharo anacceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch AT hayashikenichi anacceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch AT takeuchiayano anacceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch AT sugiyamadaisuke anacceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch AT okamuratomonori anacceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch AT aidaharo acceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch AT hayashikenichi acceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch AT takeuchiayano acceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch AT sugiyamadaisuke acceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch AT okamuratomonori acceleratedfailuretimecuremodelwithshiftedgammafrailtyanditsapplicationtoepidemiologicalresearch |